Nirsevimab therapy also effective against RSV-linked bronchiolitis resulting in critical care, ventilatory support for ...

Baseline ECG abnormality linked to increased incidence of composite end point of overall death and CVD admission.

Reduction seen in inflammatory and noninflammatory lesions, improvement seen in overall quality of life with EPA/DHA.

Additional information related to the manufacturing process and the type 1 diabetes indication will need to be provided ...

Due to the lack of an appropriate dosage strength, Velphoro is not approved in pediatric patients 6 years to less than 9 ...

Researchers found that any medication use increased from 83.9 to 90.0% during 1999 to 2000 through 2005 to 2006. HealthDay News — From 1999 to the mid-2000s, the proportion of US adults aged 65 years ...

Sofdra (sofpironium) Anticholinergic Treatment of primary axillary hyperhidrosis in adults and children 9 years of age and older. Sofdra Approved for Primary Axillary Hyperhidrosis Iqirvo (elafibranor ...

The table below is a review of notable updates that occurred in June 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. Olezarsen ...

The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve through an outpatient ...

Credit: Arcutis. The approval was supported by data from the phase 3 INTEGUMENT-1 and INTEGUMENT-2 trials. The Food and Drug Administration (FDA) has approved Zoryve ® (roflumilast) cream 0.15% for ...

Similar findings seen for those who previously used combustible cigarettes and currently use electronic cigarettes. HealthDay News — Electronic cigarette use is associated with a lower use of lung ...

Pathology, psychiatry revenue experienced robust recovery by 2022; surgery, oncology revenue remained at or below baseline.